<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04956562</url>
  </required_header>
  <id_info>
    <org_study_id>1903</org_study_id>
    <nct_id>NCT04956562</nct_id>
  </id_info>
  <brief_title>Effect of Sinovac on Survival in Intensive Care Unit</brief_title>
  <official_title>Effect of Inactivated COVID-19 Vaccine, Sinovac on Survival in Intensive Care Unit</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sisli Hamidiye Etfal Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sisli Hamidiye Etfal Training and Research Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Effect of Inactivated COVID-19 Vaccine (Sinovac) on survival in intensive care unit, Single&#xD;
      Center Experience&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Turkey has started vaccinate healthcare professionals at 13 January 2021 by Sinovac vaccine&#xD;
      and declared a step by step inclusion schedule The primary aim of the study is to compare&#xD;
      clinical, laboratory and survival data of COVID-19 patients who were vaccinated at least 14&#xD;
      days before enrollment to the study with COVID-19 patients not vaccinated although they would&#xD;
      have. The secondary aim is to compare age of enrolled patients to ICU due to SARS-CoV-2&#xD;
      infection with patients admitted to ICU before start of vaccination program.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 1, 2021</start_date>
  <completion_date type="Actual">May 15, 2021</completion_date>
  <primary_completion_date type="Actual">May 15, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>survival data</measure>
    <time_frame>30 days</time_frame>
    <description>If the patient dies, we have reached an outcome</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">96</enrollment>
  <condition>Survival</condition>
  <condition>Intensive Care Unit</condition>
  <arm_group>
    <arm_group_label>Vaccinated with sinovac</arm_group_label>
    <description>Vaccinated COVID-19 patients over 65 years consisted the study group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Unvaccinated</arm_group_label>
    <description>Unvaccinated patients over 65 years composed the control group</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients admitted to our institution's intensive care unit (ICU) between 01 April 2021 and&#xD;
        15 May 2021 was enrolled to the study. Exclusion criteria was admissions to ICU due to&#xD;
        reasons other than COVID-19, age younger than 18, continued admission at the end of&#xD;
        enrolment date.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with covid 19 over the age of 65 who were admitted to the intensive care unit&#xD;
             between 1 April 2021 and 15 May 2021&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  admissions to ICU due to reasons other than COVID-19, age younger than 65, continued&#xD;
             admission at the end of enrolment date,&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Sisli Hamidiye Etfal Research and Training Hospital</name>
      <address>
        <city>Istanbul</city>
        <zip>34771</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 30, 2021</study_first_submitted>
  <study_first_submitted_qc>June 30, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 9, 2021</study_first_posted>
  <last_update_submitted>June 30, 2021</last_update_submitted>
  <last_update_submitted_qc>June 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sisli Hamidiye Etfal Training and Research Hospital</investigator_affiliation>
    <investigator_full_name>Sultan Acar Sevin√ß</investigator_full_name>
    <investigator_title>consultant doctor</investigator_title>
  </responsible_party>
  <keyword>covid-19 vaccine</keyword>
  <keyword>sinovac</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

